mAbs

Keyphrases

Publications

volume 16, number 1, 2024

Leticia Maria De Souza Cordeiro, Kelley Christine Atkinson, Argin Aivazian, Patrick Frank Joyce, Fang Jia, Alessandro Mascioni
Electrostatic properties of human germlines and biodistribution of small biologics. mAbs 16 (1) (2024)
Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, Shauna M West, Rona M Cutler, Gillian McCluskey, Graham Craggs, Asher Maroof, Nicholas M Barnes, David P Humphreys, Stephen Rapecki, Bryan J Smith, Anthony Shock
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro . mAbs 16 (1) (2024)
Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, Shauna M West, Rona M Cutler, Gillian McCluskey, Graham Craggs, Asher Maroof, Nicholas M Barnes, David P Humphreys, Stephen Rapecki, Bryan J Smith, Anthony Shock
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro . mAbs 16 (1) (2024)
Leticia Maria De Souza Cordeiro, Kelley Christine Atkinson, Argin Aivazian, Patrick Frank Joyce, Fang Jia, Alessandro Mascioni
Electrostatic properties of human germlines and biodistribution of small biologics. mAbs 16 (1) (2024)
Jennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, Peter R McIlroy, Anupama Sinha, Ashlee M Phillips, Christopher A Sumner, Colleen M Courtney, Christina Y Kim, Dina R Weilhammer, Brooke Harmon
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function. mAbs 16 (1) (2024)
Alessandro Ascione, Marcello Belfiore, Jaana Vesterinen, Mihaela Buda, Wolf Holtkamp, Francesca Luciani
Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation. mAbs 16 (1) (2024)
Jing Dai, Saeed Izadi, Jonathan Zarzar, Patrick Wu, Angela Oh, Paul J Carter
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody. mAbs 16 (1) (2024)
Shen Luo, Baolin Zhang
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies. mAbs 16 (1) (2024)
Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)
Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)
Wei-Ching Liang, Hongkang Xi, Dawei Sun, Luigi D'Ascenzo, Jonathan Zarzar, Nicole Stephens, Ryan Cook, Yinyin Li, Zhengmao Ye, Marissa Matsumoto, Jian Payandeh, Matthieu Masureel, Yan Wu
Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability. mAbs 16 (1) (2024)
Jennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, Peter R McIlroy, Anupama Sinha, Ashlee M Phillips, Christopher A Sumner, Colleen M Courtney, Christina Y Kim, Dina R Weilhammer, Brooke Harmon
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function. mAbs 16 (1) (2024)
Dan Zhu, Haralambos Hadjivassiliou, Catherine Jennings, David Mikolon, Massimo Ammirante, Sharmistha Acharya, Jon Lloyd, Mahan Abbasian, Rama Krishna Narla, Joseph R Piccotti, Katie Stamp, Ho Cho, Kandasamy Hariharan
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin's lymphoma. mAbs 16 (1) (2024)
Alessandro Ascione, Marcello Belfiore, Jaana Vesterinen, Mihaela Buda, Wolf Holtkamp, Francesca Luciani
Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation. mAbs 16 (1) (2024)
Alessandro Ascione, Marcello Belfiore, Jaana Vesterinen, Mihaela Buda, Wolf Holtkamp, Francesca Luciani
Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation. mAbs 16 (1) (2024)
Jing Song, Marc Taraban, Y Bruce Yu, Lynn Lu, Pallavi Guha Biswas, Wei Xu, Hanmi Xi, Akhilesh Bhambhani, Guangli Hu, Yongchao Su
In-situ biophysical characterization of high-concentration protein formulations using w NMR. mAbs 16 (1) (2024)
Jing Song, Marc Taraban, Y Bruce Yu, Lynn Lu, Pallavi Guha Biswas, Wei Xu, Hanmi Xi, Akhilesh Bhambhani, Guangli Hu, Yongchao Su
In-situ biophysical characterization of high-concentration protein formulations using w NMR. mAbs 16 (1) (2024)
Shen Luo, Baolin Zhang
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies. mAbs 16 (1) (2024)
Alessandro Ascione, Marcello Belfiore, Jaana Vesterinen, Mihaela Buda, Wolf Holtkamp, Francesca Luciani
Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation. mAbs 16 (1) (2024)
Andreas Evers, Simon Krah, Deniz Demir, Ramona Gaa, Desislava Elter, Christian Schroeter, Stefan Zielonka, Nicolas Rasche, Julia Dotterweich, Christine Knuehl, Achim Doerner
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-MET. mAbs 16 (1) (2024)
Andreas Evers, Simon Krah, Deniz Demir, Ramona Gaa, Desislava Elter, Christian Schroeter, Stefan Zielonka, Nicolas Rasche, Julia Dotterweich, Christine Knuehl, Achim Doerner
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-MET. mAbs 16 (1) (2024)
Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)
Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, Shauna M West, Rona M Cutler, Gillian McCluskey, Graham Craggs, Asher Maroof, Nicholas M Barnes, David P Humphreys, Stephen Rapecki, Bryan J Smith, Anthony Shock
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro . mAbs 16 (1) (2024)
Jennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, Peter R McIlroy, Anupama Sinha, Ashlee M Phillips, Christopher A Sumner, Colleen M Courtney, Christina Y Kim, Dina R Weilhammer, Brooke Harmon
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function. mAbs 16 (1) (2024)
Jacquelyn Blake-Hedges, Dan Groff, Wilson Foo, Jeffrey Hanson, Elenor Castillo, Miao Wen, Diana Cheung, Mary Rose Masikat, Jian Lu, Young Park, Nina Abi Carlos, Hans Usman, Kevin Fong, Abigail Yu, Sihong Zhou, Joyce Kwong, Cuong Tran, Xiaofan Li, Dawei Yuan, Trevor Hallam, Gang Yin
Production of antibodies and antibody fragments containing non-natural amino acids in Escherichia coli . mAbs 16 (1) (2024)
Dan Zhu, Haralambos Hadjivassiliou, Catherine Jennings, David Mikolon, Massimo Ammirante, Sharmistha Acharya, Jon Lloyd, Mahan Abbasian, Rama Krishna Narla, Joseph R Piccotti, Katie Stamp, Ho Cho, Kandasamy Hariharan
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin's lymphoma. mAbs 16 (1) (2024)
Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, Shauna M West, Rona M Cutler, Gillian McCluskey, Graham Craggs, Asher Maroof, Nicholas M Barnes, David P Humphreys, Stephen Rapecki, Bryan J Smith, Anthony Shock
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro . mAbs 16 (1) (2024)
Wei-Ching Liang, Hongkang Xi, Dawei Sun, Luigi D'Ascenzo, Jonathan Zarzar, Nicole Stephens, Ryan Cook, Yinyin Li, Zhengmao Ye, Marissa Matsumoto, Jian Payandeh, Matthieu Masureel, Yan Wu
Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability. mAbs 16 (1) (2024)
Dan Zhu, Haralambos Hadjivassiliou, Catherine Jennings, David Mikolon, Massimo Ammirante, Sharmistha Acharya, Jon Lloyd, Mahan Abbasian, Rama Krishna Narla, Joseph R Piccotti, Katie Stamp, Ho Cho, Kandasamy Hariharan
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin's lymphoma. mAbs 16 (1) (2024)
Ammelie Svea Boje, Lukas Pekar, Katharina Koep, Britta Lipinski, Brian Rabinovich, Andreas Evers, Carina Lynn Gehlert, Steffen Krohn, Yanping Xiao, Simon Krah, Rinat Zaynagetdinov, Lars Toleikis, Sven Poetzsch, Matthias Peipp, Stefan Zielonka, Katja Klausz
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers. mAbs 16 (1) (2024)
Leticia Maria De Souza Cordeiro, Kelley Christine Atkinson, Argin Aivazian, Patrick Frank Joyce, Fang Jia, Alessandro Mascioni
Electrostatic properties of human germlines and biodistribution of small biologics. mAbs 16 (1) (2024)
Dan Zhu, Haralambos Hadjivassiliou, Catherine Jennings, David Mikolon, Massimo Ammirante, Sharmistha Acharya, Jon Lloyd, Mahan Abbasian, Rama Krishna Narla, Joseph R Piccotti, Katie Stamp, Ho Cho, Kandasamy Hariharan
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin's lymphoma. mAbs 16 (1) (2024)
Leticia Maria De Souza Cordeiro, Kelley Christine Atkinson, Argin Aivazian, Patrick Frank Joyce, Fang Jia, Alessandro Mascioni
Electrostatic properties of human germlines and biodistribution of small biologics. mAbs 16 (1) (2024)
Ammelie Svea Boje, Lukas Pekar, Katharina Koep, Britta Lipinski, Brian Rabinovich, Andreas Evers, Carina Lynn Gehlert, Steffen Krohn, Yanping Xiao, Simon Krah, Rinat Zaynagetdinov, Lars Toleikis, Sven Poetzsch, Matthias Peipp, Stefan Zielonka, Katja Klausz
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers. mAbs 16 (1) (2024)
Jing Song, Marc Taraban, Y Bruce Yu, Lynn Lu, Pallavi Guha Biswas, Wei Xu, Hanmi Xi, Akhilesh Bhambhani, Guangli Hu, Yongchao Su
In-situ biophysical characterization of high-concentration protein formulations using w NMR. mAbs 16 (1) (2024)
Jing Song, Marc Taraban, Y Bruce Yu, Lynn Lu, Pallavi Guha Biswas, Wei Xu, Hanmi Xi, Akhilesh Bhambhani, Guangli Hu, Yongchao Su
In-situ biophysical characterization of high-concentration protein formulations using w NMR. mAbs 16 (1) (2024)
Jing Dai, Saeed Izadi, Jonathan Zarzar, Patrick Wu, Angela Oh, Paul J Carter
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody. mAbs 16 (1) (2024)
Jennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, Peter R McIlroy, Anupama Sinha, Ashlee M Phillips, Christopher A Sumner, Colleen M Courtney, Christina Y Kim, Dina R Weilhammer, Brooke Harmon
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function. mAbs 16 (1) (2024)
Shen Luo, Baolin Zhang
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies. mAbs 16 (1) (2024)
Jing Dai, Saeed Izadi, Jonathan Zarzar, Patrick Wu, Angela Oh, Paul J Carter
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody. mAbs 16 (1) (2024)
Shen Luo, Baolin Zhang
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies. mAbs 16 (1) (2024)
Wei-Ching Liang, Hongkang Xi, Dawei Sun, Luigi D'Ascenzo, Jonathan Zarzar, Nicole Stephens, Ryan Cook, Yinyin Li, Zhengmao Ye, Marissa Matsumoto, Jian Payandeh, Matthieu Masureel, Yan Wu
Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability. mAbs 16 (1) (2024)
Andreas Evers, Simon Krah, Deniz Demir, Ramona Gaa, Desislava Elter, Christian Schroeter, Stefan Zielonka, Nicolas Rasche, Julia Dotterweich, Christine Knuehl, Achim Doerner
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-MET. mAbs 16 (1) (2024)
Andreas Evers, Simon Krah, Deniz Demir, Ramona Gaa, Desislava Elter, Christian Schroeter, Stefan Zielonka, Nicolas Rasche, Julia Dotterweich, Christine Knuehl, Achim Doerner
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-MET. mAbs 16 (1) (2024)
Jacquelyn Blake-Hedges, Dan Groff, Wilson Foo, Jeffrey Hanson, Elenor Castillo, Miao Wen, Diana Cheung, Mary Rose Masikat, Jian Lu, Young Park, Nina Abi Carlos, Hans Usman, Kevin Fong, Abigail Yu, Sihong Zhou, Joyce Kwong, Cuong Tran, Xiaofan Li, Dawei Yuan, Trevor Hallam, Gang Yin
Production of antibodies and antibody fragments containing non-natural amino acids in Escherichia coli . mAbs 16 (1) (2024)
Jacquelyn Blake-Hedges, Dan Groff, Wilson Foo, Jeffrey Hanson, Elenor Castillo, Miao Wen, Diana Cheung, Mary Rose Masikat, Jian Lu, Young Park, Nina Abi Carlos, Hans Usman, Kevin Fong, Abigail Yu, Sihong Zhou, Joyce Kwong, Cuong Tran, Xiaofan Li, Dawei Yuan, Trevor Hallam, Gang Yin
Production of antibodies and antibody fragments containing non-natural amino acids in Escherichia coli . mAbs 16 (1) (2024)
Ammelie Svea Boje, Lukas Pekar, Katharina Koep, Britta Lipinski, Brian Rabinovich, Andreas Evers, Carina Lynn Gehlert, Steffen Krohn, Yanping Xiao, Simon Krah, Rinat Zaynagetdinov, Lars Toleikis, Sven Poetzsch, Matthias Peipp, Stefan Zielonka, Katja Klausz
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers. mAbs 16 (1) (2024)
Wei-Ching Liang, Hongkang Xi, Dawei Sun, Luigi D'Ascenzo, Jonathan Zarzar, Nicole Stephens, Ryan Cook, Yinyin Li, Zhengmao Ye, Marissa Matsumoto, Jian Payandeh, Matthieu Masureel, Yan Wu
Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability. mAbs 16 (1) (2024)
Ammelie Svea Boje, Lukas Pekar, Katharina Koep, Britta Lipinski, Brian Rabinovich, Andreas Evers, Carina Lynn Gehlert, Steffen Krohn, Yanping Xiao, Simon Krah, Rinat Zaynagetdinov, Lars Toleikis, Sven Poetzsch, Matthias Peipp, Stefan Zielonka, Katja Klausz
Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers. mAbs 16 (1) (2024)
Silvia Crescioli, Hélène Kaplon, Alicia M Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M Reichert
Antibodies to watch in 2024. mAbs 16 (1) (2024)